4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-039056
General Counsel and Secretary sold 1,597 shares at an average $28.37 ($45,311)
- General Counsel and Secretary acquired 1,597 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara General Counsel and Secretary | 2022-12-15 | Option exercise | +300 | $23.03 | $6,909 | 300 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-15 | Sale | −300 | $28.08 | $8,424 | 0 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-16 | Option exercise | +1,297 | $23.03 | $29,870 | 1,297 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-16 | Sale | −1,297 | $28.44 | $36,887 | 0 | D |
| Derivatives | |||||||
| Meisner Lara General Counsel and Secretary | 2022-12-15 | Option exercise · Stock Option (Right to Buy) | −300 | 62,944 | D | ||
| Meisner Lara General Counsel and Secretary | 2022-12-16 | Option exercise · Stock Option (Right to Buy) | −1,297 | 61,647 | D | ||
| Open-market sales · 1,597 sh · avg $28.37 · $45,311 | |||||||
Loading xslF345X03/doc4.xml…